Direct oral anticoagulants and the bleeding patient.
作者信息
Wood Brendan, Sholzberg Michelle, Ackery Alun
机构信息
Division of Emergency Medicine (Wood, Ackery) and Division of Hematology (Sholzberg), Department of Medicine, University of Toronto; Division of Hematopathology (Sholzberg), Coagulation Laboratory and Pathobiology, Department of Laboratory Medicine, University of Toronto; and St. Michael's Hospital (Ackery, Sholzberg), Toronto, Ont.
出版信息
CMAJ. 2016 Feb 16;188(3):215. doi: 10.1503/cmaj.150604. Epub 2015 Oct 13.
Abstract
摘要
相似文献
1
Direct oral anticoagulants and the bleeding patient.直接口服抗凝剂与出血患者
CMAJ. 2016 Feb 16;188(3):215. doi: 10.1503/cmaj.150604. Epub 2015 Oct 13.
2
Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.华法林及新型药物：口腔外科医生需要了解的内容。
Oral Maxillofac Surg Clin North Am. 2016 Nov;28(4):515-521. doi: 10.1016/j.coms.2016.06.011. Epub 2016 Sep 10.
3
[Management of bleeding associated with direct oral anticoagulants: update on reversal strategies].[直接口服抗凝剂相关出血的管理：逆转策略的最新进展]
Rev Med Chil. 2019;147(1):73-82. doi: 10.4067/S0034-98872019000100073.
4
[State of the art: Direct oral anticoagulants and transfusion].[最新进展：直接口服抗凝剂与输血]
Transfus Clin Biol. 2017 Sep;24(3):154-159. doi: 10.1016/j.tracli.2017.05.019. Epub 2017 Jun 30.
5
Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.心脏病学患者专页：新型口服抗凝药所致出血的解毒剂
Circulation. 2016 Jan 12;133(2):e18-9. doi: 10.1161/CIRCULATIONAHA.115.018355.
6
Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols.依达赛珠单抗与Xa因子逆转剂：在医院指南和方案中的作用
Am J Med. 2016 Nov;129(11S):S89-S96. doi: 10.1016/j.amjmed.2016.06.010. Epub 2016 Aug 26.
7
Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.直接口服抗凝剂与维生素 K 拮抗剂治疗患者创伤性颅内出血扩大和结局的比较。
Neurocrit Care. 2020 Apr;32(2):407-418. doi: 10.1007/s12028-019-00898-y.
8
[Monitoring options and reversal agents for oral anticoagulants].[口服抗凝剂的监测选项及逆转剂]
Ugeskr Laeger. 2014 Apr 28;176(9).
9
[NOAC: Real-life data and the role of antidotes for the treatment of bleeding].[新型口服抗凝药：治疗出血的真实数据及解毒剂的作用]
Med Klin Intensivmed Notfmed. 2017 Mar;112(2):99-104. doi: 10.1007/s00063-016-0258-5. Epub 2017 Jan 31.
10
[Peri-Interventional Management of Direct Oral Anticoagulants - Balancing Benefits and Risks].[直接口服抗凝剂的围介入期管理——权衡获益与风险]
Praxis (Bern 1994). 2018 Apr;107(9-10):485-493. doi: 10.1024/1661-8157/a002963.
引用本文的文献
1
[Oral anticoagulation using coumarins - an update].[使用香豆素类药物进行口服抗凝治疗——最新进展]
Wien Med Wochenschr. 2018 Apr;168(5-6):121-132. doi: 10.1007/s10354-017-0577-z. Epub 2017 Jun 12.
本文引用的文献
1
Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.非维生素K拮抗剂口服抗凝剂与传统抗凝剂的检测：止血检测的合理应用
Thromb J. 2014 Nov 4;12:24. doi: 10.1186/1477-9560-12-24. eCollection 2014.
2
Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents.处理特定靶点口服抗凝剂相关出血，包括药理学逆转剂的最新进展。
J Thromb Thrombolysis. 2015 Apr;39(3):395-402. doi: 10.1007/s11239-015-1167-9.
3
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.新型口服抗凝剂与华法林治疗心房颤动患者的疗效和安全性比较：随机试验的荟萃分析。
Lancet. 2014 Mar 15;383(9921):955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4.
4
New anticoagulants: A concise review.新型抗凝药物：简要综述。
J Trauma Acute Care Surg. 2012 Oct;73(4):983-92. doi: 10.1097/TA.0b013e318265cf9e.
Zotero 插件